In preclinical models, rat insulinoma‑derived beta‑cell line INS‑1 (INS‑1) cells and mouse islets showed rapid, robust Viperin induction after cytokine exposure.

The gout market is poised for steady growth, driven by the rising prevalence of the disease, increasing awareness, and the launch of novel therapies such as AR-882, Epaminurad, XNW3009, XRx-026, ...

A new animal study sheds light on how a common dietary supplement may ease both gut and brain symptoms of inflammatory bowel disease. The research, published in the journal Food & Function, suggests ...

Still, getting a corneal transplant in the developing world depends upon surgical skill and available corneas, and for the underprivileged, both are in short supply. Some promising therapies are in ...

Stefano Borgonovo, Gianluca Signorini, and Pietro Anastasi are just three of more than 30 professional footballers who have died from amyotrophic lateral sclerosis (ALS), a degenerative motor neuron ...

Cancer cachexia is a complex metabolic syndrome characterized by the ongoing loss of skeletal muscle mass, with or without fat loss, that cannot be reversed entirely by conventional nutritional ...

On 03 September 2025, Hoffmann-La Roche conducted a study is to assess the long-term safety and to explore the efficacy of astegolimab in participants with chronic obstructive pulmonary disease (COPD) ...

Greek yogurt supplementation post-training significantly reduces inflammation markers in young males, offering insights into effective recovery nutrition.

Maintaining weight loss with regular exercise rather than the glucagon-like peptide-1 receptor agonist (GLP-1RA) liraglutide, a drug used to treat type 2 diabetes and obesity, seems to ...

Osteoarthritis is the most prevalent musculoskeletal disorder globally and the leading cause of chronic pain and disability. In India, over 62 million individuals are affected, with a rising ...

Canakinumab (Ilaris) may be the better option than anakinra (Kineret) when treating the rare disease called VEXAS syndrome with an interleukin-1 (IL-1) inhibitor, a multinational study indicated.